A detailed history of Avalon Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Avalon Trust CO holds 200 shares of AMGN stock, worth $57,979. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$57,979
Previous $62.5 Million 3.12%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $28,424 - $35,289
-130 Reduced 39.39%
200 $53.8 Million
Q2 2023

Aug 09, 2023

SELL
$214.27 - $253.37 $10,713 - $12,668
-50 Reduced 13.16%
330 $73.3 Million
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $85,800 - $104,576
380 New
380 $91.9 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Avalon Trust CO Portfolio

Follow Avalon Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Trust CO with notifications on news.